Member Links
CPDD June 2023 Business Meeting Minutes
June 2022 Business Meeting Minutes
CPDD June 2021 Business Meeting Minutes
CPDD June 2020 Business Meeting Minutes
Expert Panel Recommends Evidence-Based Public Health Initiatives to Address the Opioid Crisis
Bringing Science to Bear on Opioids
Useful Reading About Prescription Opioids (22 March 2016)
Abuse, Addiction, and Pain Relief
Empirical Studies on Ethics in Human Substance Abuse Research
Resources for the Regulatory Control of Drugs with Abuse Potential
- Regulatory Control of Drugs with Abuse Potential and Abuse Liability Evaluation Resources
- Single Convention On Narcotic Drugs 1961
- Convention On Psychotropic Substances 1971
- Controlled Substances Act 1970
- Controlled Substances Act 1970 + Amendments
- Scholten_International Regulatory Environment for the Abuse Liability Evaluation
- EMEA Guidelines On The Non-Clinical Investigation Of The Dependence Potential Of Medicinal Products
- Russia_Guidelines for Abuse Liability Evaluation
For referrals to preclinical and clinical consultants within the CPDD membership regarding the abuse assessment and abuse liability of drugs contact the chair of the Committee on the Abuse Liability of Drugs, Patrick M. Beardsley, Ph.D. (email:patrick.beardsley@vcuhealth.